Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter Barrett Insider Profile
4 Followers
Peter Barrett, Director at Larimar Therapeutics, holds 23.60K shares in Revvity (Ticker: RVTY), holds ― shares in Synlogic (Ticker: SYBX), holds 4.64M shares in Larimar Therapeutics (Ticker: LRMR).
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
-6.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Peter Barrett holds in companies
Most Profitable Insider Trade
Stock:
Vitae Pharma
(VTAE)
(VTAE)
Rating:Informative Buy
Date:Sep 30, 2014 - Sep 30, 2015
Return:+44.20%
The most profitable trade made by Peter Barrett
Peter Barrett's Trading History
Larimar Therapeutics
Jan 27, 2016
Director
Uninformative Buy
70.00K
$28.46M
Synlogic
Aug 30, 2017
Director
Uninformative Buy
―
―
Revvity
May 02, 2024
Director
Uninformative Buy
―
$2.62M
Vitae Pharma
Sep 30, 2014
―
Informative Buy
300.00K
$24.66M
Sciclone Pharmaceuticals
Apr 20, 2011
―
Uninformative Buy
―
$21.99M
Alnylam Pharma
―
Director
―
$1.31M
Momenta Pharma
―
―
―
$19.89K
List of latest transactions for each holding click on a transaction to see Peter Barrett's performance on stock
You May Also Like
Peter Barrett insider profile FAQ
What is the percentage of profitable transactions made by Peter Barrett?
The percentage of profitable transactions made by Peter Barrett is 20%.
What is the average return per transaction made by Peter Barrett?
The average return per transaction made by Peter Barrett is -6.20%.
What stocks does Peter Barrett hold?
Peter Barrett holds: LRMR, SYBX, RVTY, VTAE, SCLN, ALNY, MNTA stocks.
What was Peter Barrett’s latest transaction?
Peter Barrett latest transaction was an Uninformative Buy of ―.
What was Peter Barrett's most profitable transaction?
Peter Barrett’s most profitable transaction was an Informative Buy of VTAE stock on September 30, 2014. The return on the trade was 44.20%.
What is Peter Barrett's role in Larimar Therapeutics?
Peter Barrett's role in Larimar Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.